Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Clinical Practice Guideline – Newly Diagnosed and Relapsed Epithelial Ovarian Cancer

Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Ann Oncol. 2023;34(10):833-848.

González-Martín A, Harter P, Leary A, et al., on behalf of the ESMO Guidelines Committee

  • This ESMO Clinical Practice Guideline provides key recommendations for managing epithelial ovarian cancer.
  • The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up.
  • Treatment and management algorithms for early and advanced disease, as well as recurrent disease, are provided.
  • ESMO-MCBS and ESCAT scores are given to describe the levels of evidence for treatment choices including targeted therapies.
  • The multidisciplinary expert author group stems from different institutions and countries in Europe, Asia and the USA.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.